Raven Lin

Raven Lin is a seasoned professional in the biopharmaceutical industry, currently serving as the Co-Founder of Pilatus Biosciences since April 2023. Prior to this role, Raven Lin was the Head of Corporate Development at I-Mab Biopharma from September 2017 to March 2023 and the Head of Business Development at Mycenax Biotech Inc. from January 2016 to September 2017, focusing on global partnerships and novel drug licensing opportunities. Earlier experience includes leadership roles at SynCore Biotechnology Co., Ltd, where Raven Lin managed commercial operations and contributed to award-winning innovations in Taiwan, as well as roles in Sinphar Pharmaceutical Co., Ltd and the Science and Technology Unit of the Department of Health in Taiwan, where contributions to oncology drug development and nano-biotechnology advancements were made. Academic credentials include education from ESMT Berlin.